Drug Type Small molecule drug |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H19NO3 |
InChIKeyQOUZNKNYXDVAOK-QNIMBLPESA-N |
CAS Registry124731-96-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Enterococcal Infection | Preclinical | United States | 01 Apr 1994 | |
MRSA - Methicillin resistant Staphylococcus aureus infection | Preclinical | United States | 01 Apr 1994 | |
Pseudomonas aeruginosa infection | Preclinical | United States | 01 Apr 1994 |